Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWeir Group Regulatory News (WEIR)

Share Price Information for Weir Group (WEIR)

Share Price is delayed by 15 minutes
Get Live Data
2,372.00    -66.00 (-2.71%)
Bid:
2,372.00
Ask:
2,376.00
Spread: 4.00 (0.169%)
Market Cap: £6.16b
WEIR Live PriceLast checked at - London Stock Exchange

Intraday Weir Group Share Chart

Trading Statement

18 Jan 2006 07:00

Weir Group PLC18 January 2006 18 January 2006 THE WEIR GROUP PLC TRADING UPDATE The Weir Group PLC issues a trading update in advance of its preliminaryannouncement for the 12 months ending 30 December 2005 due to be published on 21March 2006. Overall, on a like for like basis, turnover from continuing operations for thesecond half of the year will be more than 10% above the same period last yearand all divisions reported second half profits ahead of those achieved in thefirst half. Profit before tax, restructuring costs and discontinued operationsfor the 12 months ended 30 December 2005, will be ahead of last year and towardsthe upper end of Reuters market estimates. (See Footnote.) Cash generation remains healthy despite the effects of cash restructuring costs,share buy back and increased working capital employed to support the strongerorder book. Divisional Trading Comment Engineering Products In our Engineering Products Division we achieved good levels of growth in orderinput, sales and profits when compared to 2004. The Minerals businesses, as anticipated, continue to benefit from buoyant marketconditions and were major contributors to a strong second half financialperformance for the Engineering Products Division. The Clear Liquid businesses achieved good levels of order input in the secondhalf of the year. The results from Gabbioneta in the final quarter, and theongoing restructuring of the Weir Pumps business both contributed to the secondhalf improvement in the profitability of the Engineering Products Division. All Valves & Controls businesses delivered an improved performance in the secondhalf of the year. The restructuring of the UK operation is nearing completionand the early benefits are reflected in the last quarter figures. Engineering Services The Services Division delivered improved progress in turnover in the second halfwith profits slightly ahead of those achieved in the first half of the year. Thedivision has continued to fund investments for its future growth in its coremarkets. Defence, Nuclear & Gas The Defence, Nuclear and Gas Division continued to make progress in the secondhalf of the year with stronger sales and margins from both operations. Acontinued good level of enquiries, coupled with higher levels of sales, willfurther improve conditions in 2006. Outlook for 2006 The strong level of input growth in 2005 and strength of the year-end order bookis expected to translate to higher sales across all divisions in the first halfof 2006. Restructuring benefits will be evident in the improved marginperformance from the UK Valves & Clear businesses, while the addition ofGabbioneta will also contribute to further progress against 2005. Footnote: The profit range of analysts forecasts on Reuters Knowledge Consensus at 9 January 2006 was £57.50 m to £62.00 m with consensus at £59.50m. Contact details: The Weir Group PLCMark Selway, Chief Executive Tel. 0141 637 7111 (switchboard);Helen Walker, Public Relations Manager (Mobile: 07789 032296) The Maitland Consultancy Tel. 020 7379 5151Suzanne Bartch This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Jun 20262:45 pmRNSDirector/PDMR Shareholding
15th May 20269:16 amRNSHolding(s) in Company
13th May 20268:47 amRNSHolding(s) in Company
11th May 20269:50 amRNSDirector/PDMR Shareholding
8th May 20261:06 pmRNSDirector/PDMR Shareholding
8th May 20268:23 amRNSHolding(s) in Company
30th Apr 20264:24 pmRNSResult of AGM
30th Apr 20267:01 amRNSCEO Succession Announcement
30th Apr 20267:00 amRNSQ1 Trading Update
21st Apr 20262:20 pmRNSDirector/PDMR Shareholding
21st Apr 20262:16 pmRNSDirector/PDMR Shareholding
21st Apr 20262:14 pmRNSDirector/PDMR Shareholding
15th Apr 20264:17 pmRNSDirector/PDMR Shareholding
14th Apr 20262:49 pmRNSDirector/PDMR Shareholding
14th Apr 20262:48 pmRNSDirector/PDMR Shareholding
13th Apr 20267:00 amRNSHolding(s) in Company
9th Apr 202610:37 amRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSDirectorate change
31st Mar 20264:10 pmRNSDirector/PDMR Shareholding
26th Mar 20267:34 amRNSHolding(s) in Company
23rd Mar 202612:06 pmRNS2025 Annual Report and 2026 Annual General Meeting
10th Mar 20269:57 amRNSDirector Declaration
6th Mar 20267:56 amRNSHolding(s) in Company
4th Mar 20262:01 pmRNSDirector/PDMR Shareholding
4th Mar 20267:00 amRNSFinal Results
3rd Mar 20267:00 amRNSWeir completes acquisition of ESEL
2nd Mar 20266:23 pmRNSHolding(s) in Company
16th Feb 20263:53 pmRNSHolding(s) in Company
30th Jan 20262:58 pmRNSHolding(s) in Company
26th Jan 202610:00 amRNS-RWeir receives 'A' score from CDP
14th Jan 20263:26 pmRNS-RWeir and Olayan announce key milestone
15th Dec 20258:36 amRNSDirectorate change
12th Dec 202510:30 amRNSWeir to acquire ESEL
4th Dec 20258:49 amRNSDirector Declaration
3rd Dec 20257:00 amRNSWeir Capital Markets Event
19th Nov 202510:02 amRNSDirector Declaration
11th Nov 20257:00 amRNSWeir completes acquisition of Fast2Mine
5th Nov 202512:20 pmRNSDirector/PDMR Shareholding
5th Nov 20257:00 amRNSQ3 Trading Update
16th Oct 20251:48 pmRNSNotification of Change in Director’s Details
16th Oct 202512:00 pmRNSWeir AUD 400m Bond Pricing
23rd Sep 202512:00 pmRNSWeir to acquire Fast2Mine
22nd Sep 20254:05 pmRNSHolding(s) in Company
22nd Sep 20259:08 amRNSHolding(s) in Company
28th Aug 20255:56 pmRNSDirector/PDMR Shareholding
28th Aug 20255:39 pmRNSWeir completes acquisition of Townley
5th Aug 20253:42 pmRNSHolding(s) in Company
31st Jul 20257:00 amRNSHalf-year Report
23rd Jul 20257:00 amRNS-RWeir retains CDP A score for climate transparency
30th Jun 202511:06 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.